March 17, 2022
Local athlete benefits from UNC Lineberger physician’s expertise
Local football player Troy Ennis and his family go through a rare cancer diagnosis and treatment together, relying on the expertise of UNC Lineberger's Ian Davis, MD.
Tag: Cancer Genetics Clinical Program
December 22, 2021
Expanded community data project will improve understanding of cancer
UNC Lineberger’s Office of Community Outreach and Engagement has begun a major, new data-driven initiative that will comprehensively describe the cancer burden in North Carolina.
December 3, 2021
Molecular aspects of ovarian and endometrial tumors mapped to the level of a single cell
Researchers led by Hector L. Franco, PhD, have determined for the first time, cell-by-cell, the genetic and epigenetic state of ovarian and endometrial tumors.
October 13, 2021
Susan G. Komen announces $1.5 million in grants for metastatic breast cancer research
Susan G. Komen has awarded three grants in support of metastatic breast cancer research as part of a collaboration between Komen, UNC Lineberger and Duke Cancer Institute, called the Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative.
September 27, 2021
New York Times: Cancer Without Chemotherapy: ‘A Totally Different World’
September 25, 2020
New vulnerability found in lung squamous cancer may facilitate drug targeting at the cellular level
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
September 8, 2020
Ramsden, Gupta awarded 5-year, $8.8 million grant to study an enzyme that has important implications for breast and ovarian cancer
Dale Ramsden, PhD, Gaorav Gupta, MD, PhD, and team will study an enzyme that is part of an important pathway that repairs damage to genomes.
February 11, 2020
Nobel laureate Sancar named recipient of 2019 Hyman L. Battle Distinguished Cancer Research Award
UNC Lineberger's Aziz Sancar, MD, PhD, has been named the 2019 recipient of the Hyman L. Battle Distinguished Cancer Research Award.
February 3, 2020
Silverstein celebrates five years as a ‘previvor’ with UNC Lineberger fundraiser
Cancer genetic testing revealed that Beth Silverstein was at high risk for breast and ovarian cancer. She took charge of her destiny and took preventive steps through surgery, and now celebrates five years as a "previvor" with a fundraiser for UNC Lineberger.
January 16, 2020
Teaming up in the lab and in life: researchers make an impact on cancer science
Yuliya Pylayeva-Gupta, PhD, and Gaorav Gupta, MD, PhD, use their natural curiosity and drive to tackle cancer through their research at UNC Lineberger.